# HDR Focal: Feasibility Study

> **NCT02918253** · NA · RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** targeted focal HDR brachytherapy
- **RADIATION:** Whole-gland HDR Brachytherapy

## Key facts

- **NCT ID:** NCT02918253
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-10-14
- **Primary completion:** 2027-11
- **Final completion:** 2027-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02918253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02918253, "HDR Focal: Feasibility Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02918253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*